InMed Pharmaceuticals Inc.
INM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001728328
In the last 90 days, InMed Pharmaceuticals Inc. insiders filed 3 open-market purchases and 0 sales; 20 institutions reported holding it in 13F filings for Q2 2026, worth $4.18M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding InMed Pharmaceuticals Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 22 | 20 | −2 |
| Shares | 467.0K | 944.9K | +477.9K (+102.3%) |
| Value | $1.55M | $2.99M | +$1.44M (+92.6%) |
New holders (3)
Institutions that held InMed Pharmaceuticals Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Penserra Capital Management LLC | 19,912 | $49.0K | 0.00% |
| Toronto Dominion Bank | 50 | $0 | 0.00% |
| Advisory Services Network, LLC | 151 | $0 | 0.00% |
Sold out (5)
Institutions that held InMed Pharmaceuticals Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Hudson Bay Capital Management LP | 161,000 | $531.0K |
| Bank of America Corp | 16,120 | $53.0K |
| JPMorgan Chase & Co | 7,472 | $36.0K |
| Bank of Montreal | 168 | $1.00K |
| Certified Advisory Corp | 30 | $0 |